poisar

Stock

Schrodinger, Inc. SDGR

$20.24+3.93%

Overview

SDGR market data

Price History

SDGR price chart · 1M
O
19.59
H
20.29
L
19.59
C
20.24
Vol
30,163.00
Source
US equities market feed
Observed
Aug 27, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$19.59
Previous Close
$19.47
Day High
$20.29
Day Low
$19.59
52 Week High
$20.48
52 Week Low
$11.60
7 Day Return
+3.29%
30 Day Return
+32.34%
90 Day Return
+32.95%
1 Year Return
+71.92%
Daily Notional Volume
$610.3K
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$1.41
Diluted earnings per share over the trailing twelve months.
Beta
1.69
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-21.0%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$10.95 – $23.02
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $1.4B · P/B 3.62 · P/S 5.30.

Company News

9 captured
Schrodinger Sees FY Drug Discovery Revenue At $65M-$75MBenzinga · Aug 5, 2026, 9:05 PM
Schrodinger Q2 Adj. EPS $0.08 Beats $(0.48) Estimate, Sales $58.889M Beat $47.228M EstimateBenzinga · Aug 5, 2026, 8:09 PM
Schrödinger Announces Strategic Agreement With Bristol Myers Squibb To Deploy Bunsen Agentic AI Co-Scientist At Scale Across Its Research OrganizationBenzinga · Aug 5, 2026, 12:31 PM
Schrödinger Rolls Out Early Access Version Of BunsenBenzinga · Jul 27, 2026, 11:35 AM
Generative AI in Drug Discovery: Revolutionizing Pharmaceutical Research and DevelopmentGlobenewswire Inc · Jul 10, 2026, 3:15 PM
Anthropic Is Going All In on Drug Discovery Just as Pharma Stops Talking About AIBenzinga · Jul 1, 2026, 11:55 AM
8-K filing — Schrodinger, Inc. (SDGR)SEC EDGAR · Jun 29, 2026, 8:29 PM
The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath ItBenzinga · Jun 16, 2026, 1:15 PM
Recursion Pharmaceuticals vs. Schrödinger: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool · Jun 2, 2026, 10:15 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock